Antithrombotic therapy management in patients with inherited bleeding disorders and coronary artery disease: A single-centre experience

Haemophilia. 2020 Mar;26(2):e34-e37. doi: 10.1111/hae.13904. Epub 2019 Dec 17.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Aged, 80 and over
  • Blood Coagulation Disorders, Inherited / complications
  • Blood Coagulation Disorders, Inherited / drug therapy*
  • Coronary Artery Disease / complications
  • Coronary Artery Disease / therapy*
  • Female
  • Fibrinolytic Agents / adverse effects
  • Fibrinolytic Agents / therapeutic use*
  • France / epidemiology
  • Hemophilia A / complications
  • Hemophilia A / drug therapy
  • Hemophilia B / complications
  • Hemophilia B / drug therapy
  • Hemorrhage / epidemiology
  • Hemorrhage / etiology
  • Hemorrhage / prevention & control
  • Humans
  • Male
  • Middle Aged
  • Myocardial Ischemia / complications
  • Myocardial Ischemia / physiopathology
  • Myocardial Ischemia / therapy
  • Platelet Aggregation Inhibitors / adverse effects
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Retrospective Studies
  • Safety
  • Treatment Outcome
  • von Willebrand Diseases / complications
  • von Willebrand Diseases / drug therapy

Substances

  • Fibrinolytic Agents
  • Platelet Aggregation Inhibitors